![](/img/cover-not-exists.png)
O85â Durable responses in anti-PD-1 refractory melanoma following intratumoral injection of a toll-like receptor 9 (TLR9) agonist, CMP-001, in combination with pembrolizumab
Milhem, Mohammed, Zakharia, Yousef, Davar, Diwakar, Buchbinder, Elizabeth, Medina, Theresa, Daud, Adil, Ribas, Antoni, Niu, Jiaxin, Gibney, Geoffrey, Margolin, Kim, Olszanski, Anthony, Mehmi, InterjitVolume:
8
Journal:
Journal for ImmunoTherapy of Cancer
DOI:
10.1136/lba2019.4
Date:
April, 2020
File:
PDF, 439 KB
2020